Literature DB >> 25151301

Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Müller cells, lens, trabecular meshwork, cornea and lacrimal gland.

Julie Sanderson1, Darlene A Dartt2, Vickery Trinkaus-Randall3, Jesus Pintor4, Mortimer M Civan5, Nicholas A Delamere6, Erica L Fletcher7, Thomas E Salt8, Antje Grosche9, Claire H Mitchell10.   

Abstract

This review highlights recent findings that describ how purines modulate the physiological and pathophysiological responses of ocular tissues. For example, in lacrimal glands the cross-talk between P2X7 receptors and both M3 muscarinic receptors and α1D-adrenergic receptors can influence tear secretion. In the cornea, purines lead to post-translational modification of EGFR and structural proteins that participate in wound repair in the epithelium and influence the expression of matrix proteins in the stroma. Purines act at receptors on both the trabecular meshwork and ciliary epithelium to modulate intraocular pressure (IOP); ATP-release pathways of inflow and outflow cells differ, possibly permitting differential modulation of adenosine delivery. Modulators of trabecular meshwork cell ATP release include cell volume, stretch, extracellular Ca(2+) concentration, oxidation state, actin remodeling and possibly endogenous cardiotonic steroids. In the lens, osmotic stress leads to ATP release following TRPV4 activation upstream of hemichannel opening. In the anterior eye, diadenosine polyphosphates such as Ap4A act at P2 receptors to modulate the rate and composition of tear secretion, impact corneal wound healing and lower IOP. The Gq11-coupled P2Y1-receptor contributes to volume control in Müller cells and thus the retina. P2X receptors are expressed in neurons in the inner and outer retina and contribute to visual processing as well as the demise of retinal ganglion cells. In RPE cells, the balance between extracellular ATP and adenosine may modulate lysosomal pH and the rate of lipofuscin formation. In optic nerve head astrocytes, mechanosensitive ATP release via pannexin hemichannels, coupled with stretch-dependent upregulation of pannexins, provides a mechanism for ATP signaling in chronic glaucoma. With so many receptors linked to divergent functions throughout the eye, ensuring the transmitters remain local and stimulation is restricted to the intended target may be a key issue in understanding how physiological signaling becomes pathological in ocular disease.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  ATP; P2X; P2Y; RPE; adenosine; cornea; diadenosine polyphosphates; eye; lacrimal gland; lens; neurotransmitter; retina; trabecular meshwork

Mesh:

Substances:

Year:  2014        PMID: 25151301      PMCID: PMC4175147          DOI: 10.1016/j.exer.2014.08.009

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  59 in total

1.  The P2Y2 receptor mediates the epithelial injury response and cell migration.

Authors:  Ilene Boucher; Celeste Rich; Albert Lee; Meredith Marcincin; Vickery Trinkaus-Randall
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-28       Impact factor: 4.249

2.  Cholinergic agonists activate P2X7 receptors to stimulate protein secretion by the rat lacrimal gland.

Authors:  Darlene A Dartt; Robin R Hodges
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-01       Impact factor: 4.799

Review 3.  Pathophysiology and therapeutic potential of purinergic signaling.

Authors:  Geoffrey Burnstock
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

4.  Hyposmotic stress causes ATP release and stimulates Na,K-ATPase activity in porcine lens.

Authors:  M Shahidullah; A Mandal; C Beimgraben; N A Delamere
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

5.  Mechanisms of ATP release by human trabecular meshwork cells, the enabling step in purinergic regulation of aqueous humor outflow.

Authors:  Ang Li; Chi Ting Leung; Kim Peterson-Yantorno; W Daniel Stamer; Claire H Mitchell; Mortimer M Civan
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

6.  Regulation of P2X7-induced pore formation and cell death in pericyte-containing retinal microvessels.

Authors:  Tetsuya Sugiyama; Hajime Kawamura; Shigeki Yamanishi; Masato Kobayashi; Kozo Katsumura; Donald G Puro
Journal:  Am J Physiol Cell Physiol       Date:  2004-10-20       Impact factor: 4.249

Review 7.  Nucleotides in ocular secretions: their role in ocular physiology.

Authors:  Almudena Crooke; Ana Guzmán-Aranguez; Assumpta Peral; M Khairul Anwar Abdurrahman; Jesús Pintor
Journal:  Pharmacol Ther       Date:  2008-05-11       Impact factor: 12.310

8.  Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina.

Authors:  Antje Wurm; Ianors Iandiev; Margrit Hollborn; Peter Wiedemann; Andreas Reichenbach; Herbert Zimmermann; Andreas Bringmann; Thomas Pannicke
Journal:  Exp Eye Res       Date:  2008-07-18       Impact factor: 3.467

9.  Regulation by P2X7: epithelial migration and stromal organization in the cornea.

Authors:  Courtney Mayo; Ruiyi Ren; Celeste Rich; Mary Ann Stepp; Vickery Trinkaus-Randall
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-23       Impact factor: 4.799

10.  Involvement of P2X(7) receptors in retinal ganglion cell death after optic nerve crush injury in rats.

Authors:  Keigo Kakurai; Tetsuya Sugiyama; Takuji Kurimoto; Hidehiro Oku; Tsunehiko Ikeda
Journal:  Neurosci Lett       Date:  2012-12-20       Impact factor: 3.046

View more
  56 in total

1.  Purinoreceptor P2X7 Regulation of Ca(2+) Mobilization and Cytoskeletal Rearrangement Is Required for Corneal Reepithelialization after Injury.

Authors:  Martin S Minns; Gregory Teicher; Celeste B Rich; Vickery Trinkaus-Randall
Journal:  Am J Pathol       Date:  2015-12-10       Impact factor: 4.307

Review 2.  The properties, functions, and pathophysiology of maxi-anion channels.

Authors:  Ravshan Z Sabirov; Petr G Merzlyak; Md Rafiqul Islam; Toshiaki Okada; Yasunobu Okada
Journal:  Pflugers Arch       Date:  2016-01-06       Impact factor: 3.657

3.  Damage to lens fiber cells causes TRPV4-dependent Src family kinase activation in the epithelium.

Authors:  M Shahidullah; A Mandal; N A Delamere
Journal:  Exp Eye Res       Date:  2015-08-25       Impact factor: 3.467

4.  Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy.

Authors:  Sirpa Loukovaara; Jouko Sandholm; Kristiina Aalto; Janne Liukkonen; Sirpa Jalkanen; Gennady G Yegutkin
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

5.  Injury-induced purinergic signalling molecules upregulate pluripotency gene expression and mitotic activity of progenitor cells in the zebrafish retina.

Authors:  Matías P Medrano; Claudio A Bejarano; Ariadna G Battista; Graciela D Venera; Ramón O Bernabeu; Maria Paula Faillace
Journal:  Purinergic Signal       Date:  2017-07-14       Impact factor: 3.765

6.  Light-induced ATP release from the lens.

Authors:  Jesús Pintor
Journal:  Purinergic Signal       Date:  2018-09-20       Impact factor: 3.765

7.  Increased Ap4A levels and ecto-nucleotidase activity in glaucomatous mice retina.

Authors:  María J Pérez de Lara; Ana Guzmán-Aranguez; Rosa Gómez-Villafuertes; Javier Gualix; María Teresa Miras-Portugal; Jesús Pintor
Journal:  Purinergic Signal       Date:  2018-06-08       Impact factor: 3.765

Review 8.  Ocular Purine Receptors as Drug Targets in the Eye.

Authors:  Kenneth A Jacobson; Mortimer M Civan
Journal:  J Ocul Pharmacol Ther       Date:  2016-08-30       Impact factor: 2.671

Review 9.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 10.  Purinergic signaling in the retina: From development to disease.

Authors:  Ana Lucia Marques Ventura; Alexandre Dos Santos-Rodrigues; Claire H Mitchell; Maria Paula Faillace
Journal:  Brain Res Bull       Date:  2018-11-17       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.